These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2906398)

  • 21. Ranitidine and cimetidine for duodenal ulcer.
    Langman MJ; Henry DA; Ogilvie A
    Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of recurrent ulceration after vagotomy for duodenal ulcer.
    Hoffmann J; Shokouh-Amiri MH
    Acta Chir Scand Suppl; 1988; 547():82-5. PubMed ID: 2906492
    [No Abstract]   [Full Text] [Related]  

  • 23. Omeprazole in H2 blocker non-responders.
    Savarino V; Mela G; Sumberaz A; Celle G
    Gut; 1990 May; 31(5):584. PubMed ID: 1972126
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of ranitidine on prognosis after simple closure of perforated duodenal ulcer.
    Singh K; Chhina RS; Ghosh A; Kaura R
    Trop Gastroenterol; 1999; 20(2):90-2. PubMed ID: 10484900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacologic control of duodenal ulcer.
    Bombeck CT
    Curr Surg; 1979; 36(4):223-6. PubMed ID: 42513
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 27. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
    Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
    Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulcer disease of the upper gastrointestinal tract.
    Meeroff JC
    Hosp Pract (Off Ed); 1984 Oct; 19(10):177-80, 190, 192 passim. PubMed ID: 6148348
    [No Abstract]   [Full Text] [Related]  

  • 30. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacotherapy in complex treatment of ulcerous stenosis].
    Rukhliada NV; Nazarov VE; Ermolaev IA
    Vestn Khir Im I I Grek; 2003; 162(3):97-100. PubMed ID: 12942622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Chassany O; Bergmann JF
    Rev Prat; 1998 Apr; 48(8):893-8. PubMed ID: 11767336
    [No Abstract]   [Full Text] [Related]  

  • 33. Is there really a need for high doses of H2 antagonists in duodenal ulcer treatment?
    Savarino V; Mela GS; Celle G
    Am J Gastroenterol; 1990 Jul; 85(7):903-5. PubMed ID: 1973593
    [No Abstract]   [Full Text] [Related]  

  • 34. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 35. Nizatidine (AXID).
    Med Lett Drugs Ther; 1988 Aug; 30(772):77-8. PubMed ID: 2899835
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indications and results of surgical treatment of ulcers. Considerations after the introduction of H2-receptor antagonists].
    Barner S; Waldmann D; Farthmann EH
    Fortschr Med; 1984 Jul; 102(25-26):692-6. PubMed ID: 6147305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 38. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamics of prostaglandin E content in patients with duodenal ulcer various treatment regimens].
    Serebrianskaia MV; Masenko VP
    Klin Med (Mosk); 1993; 71(4):45-7. PubMed ID: 7902470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seven-year follow-up of patients with duodenal ulcer disease.
    Kayser L; Møller B; Harting K; Rune SJ
    Scand J Gastroenterol; 1994 Aug; 29(8):684-7. PubMed ID: 7973427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.